Found 22 matching trials
Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma PHASE2 This is a prospective single arm, multi-center, phase II clinical trial to ...
Show More Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Learn More & Join Trial
R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma PHASE2 This research is being done to see if a PET scan that is obtained after 3 c...
Show More Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This is an open-label, multicentre, randomised phase II trial in relapsed o...
Show More Status
Active Not Recruiting
Location
The Beatson West of Scotland Cancer Centre
Learn More & Join Trial
JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma PHASE2 To evaluate the preliminary efficacy of JS203 combined with standard regime...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL PHASE2 To evaluate the efficacy and safety of Linperlisib combined with standard i...
Show More Location
Institute of Hematology & Blood Disease Hospital
Learn More & Join Trial
Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors PHASE1 High-dose chemotherapy with autologous hematopoietic stem-cell transplantat...
Show More Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy PHASE3 This phase III trial studies the side effects of sintilimab to see how well...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) PHASE1 The purpose of this trial is to measure the safety and effectiveness of epc...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone rituximab and lenalidomide rituximab and bendamustine rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin gemcitabine and oxaliplatin Epcoritamab rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone Lenalidomide rituximab, ifosfamide, carboplatin, and etoposide phosphate Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Rituximab and Lenalidomide Epcoritamab Learn More & Join Trial
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma PHASE3 This study utilizes a prospective, multicenter, randomized two-arm design t...
Show More Location
Dongyang People's Hospital
Learn More & Join Trial